Pfizer will pay up to $2.1 billion to Fosun Pharma for rights to an experimental obesity drug, marking a trend in global pharmaceutical partnerships.
[ARCHIVED]
markets
Pfizer Secures $2.1 Billion Deal for Obesity Drug Rights
© Copyright SeaNews
markets
Pfizer Secures $2.1 Billion Deal for Obesity Drug Rights
Pfizer will pay up to $2.1 billion to Fosun Pharma for rights to an experimental obesity drug, marking a trend in global pharmaceutical partnerships.
[ARCHIVED]
© Copyright SeaNews